دورية أكاديمية

989P Disease etiology and efficacy outcomes with atezolizumab plus bevacizumab (atezo-bev) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Multinational retrospective analysis

التفاصيل البيبلوغرافية
العنوان: 989P Disease etiology and efficacy outcomes with atezolizumab plus bevacizumab (atezo-bev) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Multinational retrospective analysis
المؤلفون: Kim, S., Lee, S.Y., Park, Y.G., Kim, H-D., Lee, J.J.X., Ryu, M.H., Ryoo, B-Y., Tai, D.W.M., Yoo, C.
المصدر: In Annals of Oncology October 2023 34 Supplement 2:S609-S610
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1016/j.annonc.2023.09.2133